1) Anemia/complications
贫血/并发症
2) vascular complication
血管并发症
1.
Relationship between serum uric acid and insulin resistance and vascular complications of type 2 diabetes;
血尿酸与2型糖尿病胰岛素抵抗及血管并发症的关系
2.
Results: Serum TG,TC,LDL-C,ApoB level elevated in diabetic patients and high TG,TC,LDL-C,ApoB level may be an important risk factor for type 2 diabetic vascular complications.
结果:提示2型糖尿病患者血清血脂中TG、TC、LDL-C、ApoB水平升高是血管并发症的危险因素,而HDL-C、ApoA1(抗动脉粥样硬化的指标)则明显下降。
3.
Objective To explore the occurrence of vascular complications after applying BoomerangTM(vascular closure device) to block femoral artery.
目的探讨心脏介入治疗患者应用BoomerangTM血管封堵器封堵股动脉后血管并发症的发生情况。
3) vascular complications
血管并发症
1.
The relationship between excretion rate of urinary album and vascular complications of diabetes;
尿微量白蛋白排泄率与糖尿病血管并发症的关系
2.
Objective To investigate the change of plasma von Willebrand factor cleaving protease(vWF-cp) activity level in patients with type 2 diabetes mellitus(T2DM) and to study its clinical significance in diabetes mellitus vascular complications.
目的检测2型糖尿病患者血浆血管性血友病因子裂解酶(vWF-cp)活性,探讨其在糖尿病血管并发症中的意义。
3.
Methods A clinical analyses of 30 type 2 diabetic patients with vascular complications (group A) was conducted in comparison with type 2 diabetic patients without vascular complications (group B) and patients with impaired glucose tolerance (IGT, group C).
方法选择2型糖尿病合并肾病患者30例(A组),并与2型糖尿病无血管并发症者(B组)、糖耐量受损(IGT)者(C组)作比较;同时选择有2型糖尿病家族史健康人(D组)和无2型糖尿病家族史健康人(E组)各30例作为对照,分别检测UM、ET并进行统计分析。
4) blood vessel complication
血管并发症
1.
the relationship between visceral obesity and blood vessel complication in subjects with type 2 diabetes;
2型糖尿病病人的内脏脂肪性肥胖与血管并发症的关系
2.
Objective To investigate the effects of removing artery sheath catheter at different time points on blood vessel complications after PCI operation.
目的探讨两种不同时间拔除动脉鞘管护理方法对PCI术后血管并发症的影响。
5) Ischemia/complications
缺血/并发症
补充资料：并发症
并发症
complication
又称“合并症”，指在一种疾病的发展过程中引起的另一种疾病或症状，常把后者称为前者的并发症。早期而积极的治疗可以减少并发症的发生。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条